Biweekly CHOP or THP-COP regimens in the treatment of newly diagnosed aggressive non-Hodgkin’s lymphomaA comparison of doxorubicin and pirarubicin: a randomized phase II study

被引：0
|
作者：
Hisashi Tsurumi
Toshiki Yamada
Michio Sawada
Senji Kasahara
Nobuhiro Kanemura
Yasushi Kojima
Kenji Fukuno
Takeshi Hara
Masanao Saio
Takeshi Takahashi
Masami Oyama
Keiya Ozawa
Tsuyoshi Takami
Hisataka Moriwaki
机构：
[1] Gifu University School of Medicine,First Department of Internal Medicine
[2] Gifu University School of Medicine,Department of Cellular Pathology
[3] Kisogawa Hospital,Department of Internal Medicine
[4] Takayama Red Cross Hospital,Department of Internal Medicine
[5] Jichi Medical School,Department of Hematology
[6] Gifu Municipal Hospital,Department of Hematology
来源：
Journal of Cancer Research and Clinical Oncology | 2004年 / 130卷
关键词：
Biweekly CHOP; Aggressive non-Hodgkin’s lymphoma; Pirarubicin; Doxorubicin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：107 / 113
页数：6
相关论文
共 15 条
  • [1] Biweekly CHOP or THP-COP regimens in the treatment of newly diagnosed aggressive non-Hodgkin's lymphoma - A comparison of doxorubicin and pirarubicin: a randomized phase II study
    Tsurumi, H
    Yamada, T
    Sawada, M
    Kasahara, S
    Kanemura, N
    Kojima, Y
    Fukuno, K
    Hara, T
    Saio, M
    Takahashi, T
    Oyama, M
    Ozawa, K
    Takami, T
    Moriwaki, H
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2004, 130 (02) : 107 - 113
  • [2] CHOP or THP-COP regimens in the treatment of newly diagnosed peripheral T-cell lymphoma, not otherwise specified: a comparison of doxorubicin and pirarubicin
    Shibata, Yuhei
    Hara, Takeshi
    Kasahara, Senji
    Yamada, Toshiki
    Sawada, Michio
    Mabuchi, Ryoko
    Matsumoto, Takuro
    Nakamura, Nobuhiko
    Nakamura, Hiroshi
    Ninomiya, Soranobu
    Kitagawa, Junichi
    Kanemura, Nobuhiro
    Kito, Yusuke
    Goto, Naoe
    Miyazaki, Tatsuhiko
    Takami, Tsuyoshi
    Takeuchi, Tamotsu
    Shimizu, Masahito
    Tsurumi, Hisashi
    HEMATOLOGICAL ONCOLOGY, 2017, 35 (02) : 163 - 171
  • [3] A multicenter, phase II study of full-dose THP-COP therapy for elderly patients with newly diagnosed, advanced-stage, aggressive non-Hodgkin lymphoma
    Ohmachi, Ken
    Ogura, Michinori
    Kagami, Yoshitoyo
    Imai, Yosuke
    Hirose, Takayuki
    Kinoshita, Tomohiro
    Nagai, Hirokazu
    Ohnishi, Kazunori
    Hotta, Tomomitsu
    JOURNAL OF CLINICAL AND EXPERIMENTAL HEMATOPATHOLOGY, 2022, 62 (04) : 202 - 207
  • [4] Long-term Results of a Multicenter Randomized, Comparative Trial of Modified CHOP versus THP-COP versus THP-COPE Regimens in Elderly Patients with Non-Hodgkin’s Lymphoma
    Mayumi Mori
    Kiyoshi Kitamura
    Michihiko Masuda
    Tomomitsu Hotta
    Tamotsu Miyazaki
    Akira B. Miura
    Hideaki Mizoguchi
    Akira Shibata
    Hidehiko Saito
    Tamotsu Matsuda
    Toru Masaoka
    Mine Harada
    Yoshiyuki Niho
    Fumimaro Takaku
    International Journal of Hematology, 2005, 81 : 246 - 254
  • [5] Long-term results of a multicenter randomized, comparative trial of modified CHOP versus THP-COP versus THP-COPE regimens in elderly patients with non-Hodgkin's lymphoma
    Mori, M
    Kitamura, K
    Masuda, M
    Hotta, T
    Miyazaki, T
    Miura, AB
    Mizoguchi, H
    Shibata, A
    Saito, H
    Matsuda, T
    Masaoka, T
    Harada, M
    Niho, Y
    Takaku, F
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2005, 81 (03) : 246 - 254
  • [6] Influence of amifostine on toxicity of CHOP in elderly patients with aggressive non-Hodgkin's lymphoma -: a phase II study
    Späth-Schwalbe, E
    Lange, C
    Genvresse, I
    Krüuger, L
    Eucker, J
    Schweigert, M
    Sezer, O
    Budach, V
    Possinger, K
    ANTI-CANCER DRUGS, 2002, 13 (04) : 395 - 403
  • [7] Randomized phase II study of biweekly CHOP and dose-escalated CHOP with prophylactic use of lenograstim (glycosylated G-CSF) in aggressive non-Hodgkin's lymphoma: Japan Clinical Oncology Group Study 9505
    Itoh, K
    Ohtsu, T
    Fukuda, H
    Sasaki, Y
    Ogura, M
    Morishima, Y
    Chou, T
    Aikawa, K
    Uike, N
    Mizorogi, F
    Ohno, T
    Ikeda, S
    Sai, T
    Taniwaki, M
    Kawano, F
    Niimi, M
    Hotta, T
    Shimoyama, M
    Tobinai, K
    ANNALS OF ONCOLOGY, 2002, 13 (09) : 1347 - 1355
  • [8] A randomized comparison of the efficacy and toxicity of epirubicin and doxorubicin in the treatment of patients with non-Hodgkin's lymphoma
    Nair, R
    Ramakrishnan, G
    Nair, NN
    Saikia, TK
    Parikh, PM
    Joshi, SR
    Soman, CS
    Mukhadan, M
    Dinshaw, KT
    Advani, SH
    CANCER, 1998, 82 (11) : 2282 - 2288
  • [9] Results of treatment with cyclophosphamide, doxorubicin, vincristine and prednisone (CHOP) for non-Hodgkin's aggressive lymphoma analyzed according to the International Prognostic Index
    Aydin, F
    Ulusoy, S
    Ovali, E
    JOURNAL OF CHEMOTHERAPY, 1997, 9 (06) : 446 - 451
  • [10] Gem-(R)CHOP versus (R)CHOP: a randomized phase II study of gemcitabine combined with (R)CHOP in untreated aggressive non-Hodgkin's lymphoma - EORTC lymphoma group protocol 20021 (EudraCT number 2004-004635-54)
    Aurer, Igor
    Eghbali, Houchingue
    Raemaekers, John
    Khaled, Hussein M.
    Fortpied, Catherine
    Baila, Liliana
    van der Maazen, Richard W. M.
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2011, 86 (02) : 111 - 116
12